A child-first approach to cancer immunotherapy through next-generation cancer gene therapies harnessing the power of children’s immune systems.Awarded 1st prize at Hack4Hope 2025.
Décembre 2025
UK - Londres
Immunotherapy
Biotech - Lead optimization